Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Monoclonal Gammopathy of Undetermined Significance × Curcumin × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3 Genitourinary 1

Conditions

Prostatic Neoplasms 8 Smoldering Multiple Myeloma 1 Prostate Cancer Metastatic Castration Resistant 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Castration Sensitive Prostate Cancer 1

Interventions

piperine 1 liposomal amphotericin B 1 Fentanyl 1 Curcumin 1 Caspofungin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04731844 2024-07-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

University of Rochester

Phase 2 Recruiting

GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡